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Summary Paracrine influences from fibroblasts derived from different sources of breast tissue on epithelial
breast cancer cell growth in vitro were investigated. Medium conditioned (CM) by fibroblasts derived from
tumours, adjacent normal breast tissue, and normal breast tissue obtained from reduction mammoplasty or
from skin tissue significantly stimulated the growth of the steroid-receptor positive cell lines MCF-7 and ZR
75.1. The proliferation index (PI) on MCF-7 cells with CM from fibroblasts derived from breast tumour tissue
was significantly higher than that obtained with fibroblasts derived from adjacent normal breast tissue
(2p<0.05, n = 8). The PI obtained with CM from normal fibroblast cultures from reduction mammoplasty
tissue, like normal tissue adjacent to the tumour, fell in the lower range of values. Skin fibroblast, like tumour
tissue derived fibroblast, CM caused a high range PI. MDA-MB-231 and Evsa-T, two steroid-receptor
negative cell lines, showed only a minor growth stimulatory responses with some of the fibroblast CM's.
Evsa-T was occasionally inhibited by CM's. In conclusion, stromal factors play a role in the growth regulation
of human breast cancer cells. The effects on cancer cell growth are, however, varying depending on the source
of the stroma and the characteristics of the epithelial tumour cells.
Various growth factors influence the growth of human breast
cancer cells in vitro (Lippman et al., 1986a; Lippman et al.,
1987). It has been suggested that both autocrine and para-
crine mechanisms may play a role in vivo (Lippman et al.,
1986a; Lippman et al., 1987; Osborne & Arteaga, 1990a).
Paracrine influences, whereby surrounding stromal tissues
secrete factors that interact with neighbouring epithelial cells,
may be of more importance than previously presumed (Tan-
zer & Spring-Mills, 1984; Lippman et al., 1986b).
Interaction between malignant breast-derived epithelial
cells and fibroblasts has been demonstrated both in vitro and
in vivo (Horgan et al., 19871; Adams et al., 1988a). Only very
scant data concerning the influences of stroma from normal
breast tissue on tumour growth have been reported (Adams
et al., 1988a; Horgan et al., 1987). Some observations sup-
port the hypothesis that normal breast stroma derived from
non-cancerous parts of the tumour-bearing breast in involved
in the growth regulation of breast cancer (Horgan et al.,
1987). In addition it has been shown that a fibroblast-derived
polypeptide from malignant breast tumours cause a signifi-
cant increase of epithelial 17-beta-estradiol dehydrogenase
activity, thereby increasing the local concentration of estra-
diol (Adams et al., 1988b). Moreover, exposure of human
foetal fibroblasts to antioestrogens induces the secretion of
active transforming growth factor-beta, despite the absence
of oestrogen receptor within these cells (Colletta et al., 1990).
Acknowledging the importance of paracrine influences in
general, on the behaviour of breast cancer cells, we have
investigated the involvement of stroma derived factors on the




Fibroblasts were grown from surgically removed breast or
skin tissues. Fresh tissue was obtained from malignant breast
tumours (n = 8), from normal breast tissue adjacent to malig-
nant tumours (n = 8), from normal breast tissues from reduc-
tion mammoplasties (non-tumour containing breasts, n = 2)
and from skin tissue (n = 2). The histological diagnosis of the
tissues was determined by standard histo-pathological investi-
gations. The tissue was trimmed by excessive fat and minced
into pieces of ± 1 mm3, incubated at 37C for 18-24 h in
growth medium (G-medium: a 1:1 mixture of HAM F12:
DMEM medium containing 4.5% bovine calf serum (Hyc-
lone Laboratories, UK), 2 mM glutamine, 10 mM NaHCO3,
100 U ml-' streptomycin, 100 gg ml-' penicillin, 45 ftg ml1-'
gentamycin, 10,jg ml-' insulin) supplemented with 200 U -
ml-' type I collagenase (Sigma, St Louis, USA).
The cell suspension obtained was centrifuged at 100g for
5 min, resuspended in G-medium and centrifuged again. The
cells were subsequently resuspended in complete growth
medium, which consists of G-medium without bovine calf
serum, but containing 4.5% foetal calf serum (Hyclone Lab-
oratories), 0.1 mM ethanolamine, 0.1 mM phospho-ethanol-
amine, 5 1sg ml-' transferrin (Sigma), and 1 fig ml-' prolactin
(Sigma). The epithelial cell clumps were allowed to sediment
in a conical polystyrene tube for 30 min at gravity. The
supernatant containing the fibroblasts was aspirated and the
cells were seeded into a 75 cm2 tissue culture flask, allowed to
attach and grown to subconfluence at 37°C in 5% CO2 in air
during 1-2 weeks with periodic medium changes. Sub-
confluent cultures were passaged by trypsinisation (1:2 split).
The final cultures, after 4 to 6 passages, were noted by light
microscopy to consist of only fibroblasts with no contam-
inating epithelial elements.
Fibroblast conditioned medium
Subconfluent fibroblast cultures (1 - 1.5 x 106 cells/75 cm2
flask) were rinsed twice with phosphate buffered saline (PBS)
and preincubated twice for 1 h at 37°C in 5% CO2 in air with
either serum free medium (SF-medium) or a medium contain-
ing steroid-depleted serum (DCC-medium). SF-medium con-
sists of DMEM/HAM F12 [1:1], without phenol red, but
containing 10mM NaHCO3, 4mM glutamine, 100Uml-'
streptomycin, 100 ig ml1' penicillin, 45fig ml1' gentamycin,
0.2% bovine serum albumin (BSA, purified, Behringwerke,
AG, Marburg, Germany) and 30 nM Na2Se203. In DCC-
medium BSA and Na2Se203 of the SF-medium were replaced
by 2.5% dextran-coated charcoal treated foetal calf serum.
After preincubation, 12 ml of fresh SF-medium (or DCC-
medium) was added and conditioned for three consecutive
periods of 3 days. After every 3 days the conditioned medium
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was aspirated, centrifuged at 1500g for 10min, and the
supernatant was stored at - 20°C prior to use. Equal aliquots
of SF-medium (or DCC-medium) were sham incubated in the
absence of fibroblasts, but otherwise treated in an identical
manner.
Cell culture
MCF-7 (ER +/PR +) and MDA-MB-231 (ER -/PgR-)
cells were obtained from the American Type Culture Collec-
tion (Rockville, Md, USA). ZR 75.1 (ER +/PgR +) cells
were a gift from Dr R.J.B. King (Imperial Cancer Research
Fund, London, UK). Evsa-T (ER -/PgR -) were a gift from
Dr N. DeVleeschouwer (Institut Jules Bordet, Brussels, Bel-
gium). Cells were routinely grown in their respective com-
plete growth medium. For MCF-7 cells: RPMI-1640 medium
containing phenol red, 10 mM NaHCO3, 2 mM glutamine,
100 U ml-' streptomycin, 100figml-' penicillin, 100figml-'
porcine insulin, and 10% bovine calf serum (heat-inactivated
30 min at 56°C). For ZR 75.1 insulin was substituted for
1 nM oestradiol. Complete growth medium for Evsa-T cells
consisted of DMEM/HAM-F12 medium, containing fenol
red and 14 mM HEPES, and supplemented with the same
additives as for routine MCF-7 cell culture, with the excep-
tion that 5% heat inactivated bovine calf serum was added.
MDA-MB-231 cells were cultured in the same medium as
Evsa-T cells however in the presence of 10% heat-inactivated
bovine calf serum instead of 5%.
Proliferation experiments
Cell proliferation was studied with the use of a colorimetric
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay (Carmichael et al., 1987). This assay is based
upon the ability of viable cells to reduce the tetrazolium-
based compound to a blue formazan product. The MTT
assay can be semiautomated because it can be performed in
96-well plates. MTT formazan production can then be ana-
lysed at 510nm using a scanning multiwell spectrophoto-
meter (Carmichael et al., 1987). Briefly, the cells were seeded
at a density of 5.000 cells/200fd per well (for MCF-7 and
MDA-MB-231) or 10.000 cells/200fi. per well (for ZR75.1
and Evsa-T) into 96-well culture plates and allowed to
attach. Following overnight incubation the medium was
removed, the cells thoroughly washed with PBS, and experi-
mental e.g. complete growth medium, fibroblast-conditioned
or sham-incubated medium was then added. The MMT assay
was performed in replicates of eight for each sample. Cell
proliferation was studied at days 3, 4 and 5 after the addition
of the experimental medium. On day three, fresh experiment-
al medium was added. For the cell lines used we established a
linear relation between the MTT-assay and cell number
within the range of the experiments shown.
A proliferation index (PI) of the various conditioned media
was calculated as follows:
PI = (A - C)
(B - C)
where A is the optical density (A510) of cells incubated with
fibroblast conditioned medium; B is the A510 of cells in their
own complete growth medium and C is the A510 of cells
incubated with control medium (sham incubated). A PI>1
means a growth stimulatory effect stronger than that caused
by complete medium. Ratio's between 0 and 1 reflects addi-
tional growth compared to that by the sham incubated con-
trol medium, but a reduced proliferative effect compared to
cell cultures with complete growth medium. Ratio's <0
indicate a growth effect smaller than obtained in sham
incubated control medium.
Results
In order to elucidate stromal growth effects on human
epithelial breast cancer cells, we have studied the proliferative
capacity of conditioned media derived from fibroblasts iso-
lated from different tissue sources.
Proliferation ofthe breast cancer cells in various media
The proliferative effect of various media on the breast cancer
cell line MCF-7 was studied at days 3, 4 and 5 after the
addition of the experimental media. Figure 1 illustrates the
proliferation of MCF-7 cells in complete growth medium
(cGM), sham incubated serum-free medium and fibroblast
conditioned serum-free medium (C-SFM). MCF-7 cell growth
in cGM, containing 10% serum and insulin, was used as a
proliferation reference in the experiments performed. MCF-7
cells seeded at 5000 cells/well will reach near confluence in 5
days when grown in cGM. Cell growth in sham incubated
serum-free medium, lacking any growth-factors, was used as
a reference for spontaneous growth. Only a very low level of
proliferation could be observed (Figure 1) in the presence of
SF-medium. By contrast C-SFM from fibroblasts derived
from normal mammary tissue in the tumour-bearing breast
significantly stimulated the growth of MCF-7 cells (Figure
la), although not so strong as cGM (0<PI<1). The ob-
tained additional proliferative effect, when compared to its
sham incubated SF-medium, is already evident at day 3 of
culture and increases with time. The C-SFM induced growth
stimulatory effect can be gradually reduced upon dilution
with control SF-medium (Figure la). In marked contrast,
conditioned SF-medium by human skin derived fibroblasts
(Figure lb) exhibit a more pronounced proliferative effect on
MCF-7 cells compared to cGM (PI> 1). This effect could
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Figure 1 Proliferation of MCF-7 cells in conditioned serum free
medium from fibroblasts derived from either normal tissue in a
tumour bearing breast a or human skin tissue b. Proliferation was
studied in growth medium (GM), containing serum and insulin
(-*-); in sham incubated control serum-free medium (-V-);
in fibroblast conditioned serum free medium (-A-); in fibro-
blast conditioned medium diluted three times with SF-medium
(--O--) or fibroblast conditioned serum free medium diluted
nine times with SF-medium (--O--). Values are expressed as
the mean absorbance at 510 nm of eight-fold incubations. Mean
coefficient of variation of the individual data points was
10.7 ± 4.2% (± s.d., n = 32).PARACRINE ACTIONS IN BREAST CANCER 79
Effect offibroblast C-SFM and C-DCCfrom various tissue
sources on theproliferation ofvarious cell lines
In an exploratory study we have tested both serum-free and
DCC-containing conditioned media from fibroblasts derived
from five tissue sources on four human breast cancer cell
lines with different characteristics. Results are shown in Table
I. All five C-SFM samples showed a strong proliferative
effect (PI>0.4) on MCF-7 cells. Both the skin derived
fibroblast C-SFM and that of one of the tumours stimulated
the cell growth even stronger than cGM (PI> 1). The fibro-
blast C-SFM of the other tumour with the lowest PI of a
series of C-SFM's derived from eight tumours (see Figure 2)
had less pronounced growth stimulatory effects. Conditioned
DCC-medium, with the exception ofthat derived from reduc-
tion tissue and one of the tumours, showed enhanced pro-
liferation of MCF-7 cells. The stimulation was significantly
stronger when compared to cGM.
Table I Proliferation index values obtained with conditioned
serum-free or DCC containing medium from fibroblast on various cell
lines
Fibroblasts derivedfrom
'Normal' Tumour I Tumour 2 Skin Reduction
C-SFM
MCF-7 .56 .44 2.2 1.8 .67
ZR-75.1 .34 .30 .19 .17 .22
MDA .24 .19 .04 0 0
Evsa-T 0 0 0 0 0
C-DCC
MCF-7 1.4 .33 1.65 1.65 0
ZR-75.1 .65 .56 .25 .12 .07
MDA 0 0 .07 -.26 0
Evsa-T -1.76 -1.1 0 .15 0
Fibroblasts were derived from normal breast tissue adjacent to
malignant tumour (='normal'), two malignant tumour tissues, skin












The growth of the cell line ZR 75.1 was only marginally
stimulated by the tested C-SFM samples compared to the
sham incubated controls (PI values .17 to .34). C-DCC
medium from 'normal' fibroblast derived from a tumour
bearing breast showed a quite strong induction of prolifera-
tion (PI.65). Only a small to moderate proliferative effects
were seen with C-DCC media from reduction mammoplasty,
skin and tumour derived fibroblasts (PI from .07 to .56).
MDA-MB-231 cells mainly show a minor proliferative res-
ponse to C-SFM sample from normal fibroblasts adjacent to
the tumour and to tumour sample 1. No relevant stimulatory
effects were noted with any of the other conditioned media
tested when compared to their respective controls. A minor
inhibition was caused by skin C-DCC medium. No changes
in the proliferation of Evsa-T cells were observed with any of
the C-SFM samples. C-DCC medium from normal tissue
fibroblasts from a tumour bearing breast and one of the
tumour samples strongly inhibited cell growth compared to
the sham incubated control (PI is - 1.76 and - 1.1 respec-
tively). A minor increase in proliferation was seen with C-
DCC from skin fibroblasts. We subsequently examined the
proliferation induction more extensively on MCF-7 cells with
conditioned serum-free media from fibroblasts derived from
both eight different normal mammary tissues adjacent to
malignant tumours and from eight maligant tumour tissues
from different patients. Table II shows the proliferation index
at day 4 after the addition of the various C-SFM's to MCF-7
cell cultures. All C-SFM fractions from the normal tissue
derived fibroblasts were able to cause enhanced proliferation
when compared to the effect with sham incubated control
SF-medium. However only two samples (no. 5 and 8) showed
a proliferation index over 1 (i.e. a more rapid proliferation
than with its own cGM). By contrast seven of the eight
tumour derived fibroblast conditioned media showed a pro-
liferation index over 1. The proliferation index distribution of
the individual samples is shown in Figure 2. The PI obtained
with tumour tissue derived fibroblast C-SFM was
significantly higher than the PI obtained with normal tissue
fibroblasts C-SFM (Mann Whitney U test; 2P<0.05).
We further examined the proliferative effect of two mam-
mary reduction and two skin tissue fibroblast conditioned
media on MCF-7 cells (Table III). Both samples of the two
tissue types were able to stimulate proliferation of MCF-7
cells compared to their sham incubated controls. The mam-
mary reduction tissue derived fibroblast C-SFM fractions
both showed a proliferation index comparable to the lower
values found for fibroblast C-SFM from normal breast adja-







Table II Proliferation index values obtained in two separate
experiments with conditioned serum free media ofnormal breast tissue
adjacent to malignant tumour and malignant tumour tissue fibroblasts
of different patients using MCF-7 cells.
'Normal' tissuefibroblasts Tumour tissuefibroblasts
exp. I exp. 2 mean exp. I exp.2 mean
1 .53 .44 .49 1.17 - 1.17
2 .46 .78 .62 .31 .53 .44
3 .63 .38 .51 1.30 - 1.30
4 .69 .98 .84 2.43 2.00 2.22
5 1.44 1.43 1.44 .92 2.35 1.64
6 .55 .76 .66 1.98 1.86 1.92
7 1.13 .85 .99 1.80 - 1.80
8 1.16 1.31 1.24 1.99 2.13 2.06
Figure 2 Proliferation index of MCF-7 cells cultured in condi-
tioned serum free medium derived of fibroblasts from normal
breast tissue (adjacent to tumour tissue), tumour tissue, reduction
breast tissue and skin. Individual PI values determined by the
mean of two separate estimations (apart from three tumour tissue
fractions) are given in the crossed squares. The dotted line
represents the proliferation index obtained with GM-medium
(including 10% serum and 10 g ml- insulin). The continuous
line represents the median of the individual data points.
Table III Proliferation index values obtained in separate experiments
with conditioned serum free media from reduction mammoplasty or
skin tissue fibroblasts on MCF-7 cells
Reduction tissuefibroblasts Skinfibroblasts
exp. 1 exp. 2 mean exp. I exp.2 mean
1 .67 .67 .67 1.58 1.90 1.74
2 .55 .53 .54 1.38 1.73 1.5680 C.E.P. VAN ROOZENDAAL et al.
fibroblast C-SFM samples showed a proliferation index
which was more pronounced than cGM, and were com-
parable to the values obtained with tumour derived fibro-
blasts (Figure 2).
Discussion
Both in vitro and in vivo mammary epithelial cell growth is
regulated by steroid hormones and polypeptide growth fac-
tors (Lippman et al., 1986a; Lippman et al., 1987; Osborne et
al., 1990b; Rosen et al., 1991). Little is however known about
epithelial-stromal interactions in the breast. There is con-
siderable speculation that the stroma plays an active role in
determining breast epithelial behaviour (Tanzar & Spring-
Mills, 1984; Lippman et al., 1986a; Lippman et al., 1986b;
Yee et al., 1988). So far conflicting data have been reported
in the literature (McGrath, 1983; Enami et al., 1983; Haslam,
1986; Horgan et al., 1987; Adams et al., 1988a; Miller &
McInerney, 1988).
In this report we describe the proliferative effects of fibro-
blasts from different sources on the growth of human breast
cancer cell lines. We have been able to demonstrate that
conditioned serum-free medium by both normal and tumour
derived fibroblasts can stimulate MCF-7 proliferation. Fibro-
blasts derived from malignant tumour tissue however display-
ed a significantly higher (2P<0.05, n = 8), Mann Whitney U
test) proliferation index on MCF-7 cells when compared to
those derived from normal tissue adjacent to the tumour.
Reduction mammoplasty derived tissue fibroblasts were able
to induce a proliferative effect similar to fibroblasts derived
from normal tissue in a tumour bearing breast. Although at
present we can not discriminate between qualitative and/or
quantitative variations with respect to the secreted growth
factors, all samples were derived from equivalent number of
cells. We therefore believe that the differential effect observed
is most likely determined by the phenotypic characteristics of
the fibroblast cells involved. Our results are in agreement
with those of previously reported studies (Enami et al., 1983;
Horgan, et al., 1987; Miller & McInerney, 1988). Enami et al.
(1983) reported mammary epithelial cell growth stimulation
with conditioned medium from normal fibroblasts. Horgan et
al. (1987) described a stimulation of MCF-7 carcinogenesis in
nude mice with all types of fibroblasts investigated. Further-
more Miller & McInerney (1988) reported enhancement of
the growth of mouse mammary tumours in vivo in the
presence of both normal mammary stromal and epithelial
cells. Like the present study, Adams (1988a) also showed
strong growth stimulation of steroid receptor positive MCF-7
cells in culture in the presence of tumour derived fibroblast
conditioned medium, but in contrast to our study, they
found a growth inhibitory effect of normal tissue derived
fibroblast conditioned DCC-medium on MCF-7 cells. In
addition McGrath (1983) previously reported a growth inhib-
itory effect of normal mouse mammary fibroblasts on normal
neighbouring epithelial cells, although this could not be
confirmed by Haslam (1986).
The stimulation of tumour cell growth in conditioned
medium is consistent with the secretion of stimulatory fibro-
blast derived growth factors and/or the inability to produce
active growth inhibitory factors (Clemmons et al., 1981;
Clemmons, 1984; Story et al., 1989; Yee et al., 1988). We
have also shown a high proliferation effect of human skin
tissue derived fibroblast C-SFM on MCF-7 cells. This could
be due to the production of insulin-like growth factor (IGF-
I) which was shown to be produced by skin fibroblasts
(Clemmons et al., 1981; Clemmons, 1984). Skin fibroblasts
have also been shown to express high levels of IGF II
mRNA (Yee et al., 1988). In our explorative studies using
various breast tumour cell lines varied proliferative effects
were obtained. The steroid-receptor positive MCF-7 cells
responded strongly to the conditioned media. A proliferative
response, although only small, was also noted with another
ER +/PR +) cell line, ZR 75.1. The steroid receptor negative
cell line MDA-MB-231 showed some proliferative response,
although very small, to some of the tested media. Evsa-T,
another steroid receptor negative cell line, only showed a
minor response to skin tissue derived fibroblast C-DCC. A
strong growth inhibition compared to sham incubated con-
trol medium was however noted using C-DCC medium. The
variation in growth responses of the different cell lines to the
used conditioned media in our study is most likely explained
by differences in receptor phenotypes of these cells or maybe
in secretion of different levels and/or types of growth factor
binding proteins (Osborne et al., 1990b; Yee et al., 1991).
Furthermore, recent data have shown that malignant fibro-
blasts allow the increased availability of biologically active
steroids by an effect of a secreted polypeptide on intracellular
enzyme activity, i.e. reductive 17 P-oestradiol dehydrogenase
(Adams et al., 1988b). Steroid hormone influences cell pro-
liferation partly through the secretion of growth regulators
(Lippman et al., 1986b, Dickson et al., 1987), but blockade of
receptors for IGF-1 and TGFx by monoclonal antibodies
does not prevent oestradiol-stimulated growth (Osborne et
al., 1990b).
With the numerous factors involved, the true nature of the
paracrine effects involved in the growth regulation of breast
tumours remains indetermined. It cannot be excluded that
fibroblasts from different sources secrete both growth stimu-
latory and/or growth inhibitory factors in altered ratios. On
the other hand, the receptor status of different tumour cells
within a heterogeneous tumour with respect to steroid hor-
mones, peptide hormones and growth factors is also of
importance. The reported differences in frequency and
affinity of IGF-I receptors between malignant breast
tumours, benign tumours and normal breast tissue is
therefore ofmuch interest (Pekonen et al., 1988; Peyrat et al.,
1988). However, the paracrine model is increasingly complex
and other as yet indetermined factors may play a role as well
(Ervin et al., 1989; Garin-Chesa et al., 1990). Identification of
the factors involved in the various effects described neces-
sitates further study.
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